Publication | Closed Access

Angiotensin-converting enzyme inhibitor as a risk factor for the development of anemia, and the impact of incident anemia on mortality in patients with left ventricular dysfunction

Incident AnemiaHypertensionHeart FailureCardiovascular DiseaseLeft Ventricular DysfunctionAntihypertensive TherapyMyocardial InfarctionMedicineAtherosclerosisDiastolic FunctionEmergency MedicineAnesthesiologyAngiotensin-converting Enzyme Inhibitor